Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTAGE: Simvastatin in Gastroesophageal Adenocarcinoma
NCT07625930Phase 2Not yet recruiting
- Sponsor
- McGill University Health Centre
- Start
- Jan 2027
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in gastroesophageal adenocarcinoma, sponsored by McGill University Health Centre. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
simvastatin
03
Conditions
gastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT07625930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625930.